Article Link: FDA Approves Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for Cystic Fibrosis Patients Ages 12 and Older Who Have at Least ...

Article Link: Janssen Announces FDA Approval of Stelara (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Coliti...

Article Link: FDA Approves Farxiga (dapagliflozin) to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type 2 Diabetes
...

Article Link: FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne REHOVOT, Israel and BRIDGEWATER...

Article Link: Alexion Receives FDA Approval for Ultomiris (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (AHUS) BOSTON October...

Article Link: Genentech Announces FDA Approval of Xofluza (baloxavir marboxil) for People at High Risk of Developing Influenza-Related Complications&#...

Article Link: FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia Miami, FL And Jersey Cit...

Article Link: FDA Approves Xarelto (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients RARITAN, N.J., October 14, 2...

Article Link: FDA Approves Reyvow (lasmiditan), the First Serotonin (5-HT) 1F Receptor Agonist for the Acute Treatment for Migraine INDIA...

Article Link: FDA Approves Quzyttir (cetirizine) Injection for the Treatment of Acute Urticaria October 11, 2019 – The U.S. Food an...